Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients


Bisgin A., Yalcin A. D., Gorczynski R. M.

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.96, sa.3, 2012 (SCI-Expanded) identifier identifier identifier

Özet

We examined the association between serum sTRAIL measured by ELISA and HbA1C levels, pre/post-prandial blood glucose levels and body mass index in 22 newly diagnosed type-2 diabetic patients.